Caribou Biosciences CRBU
NASDAQ CRBU
$0.54 -0.01 (-1.16%)
As of: Oct 22, 2026 · 2:21 PM EDT

Caribou Biosciences (CRBU) Long-Term Debt Repayments (2020 - 2021)

Updated

Caribou Biosciences (CRBU) reported Long-Term Debt Repayments of $119,000 for FY2021, up 5.3% from $113,000 in FY2020.

Analysis

Caribou Biosciences (CRBU) Long-Term Debt Repayments (2020 - 2021) Analysis & Trends

  • According to Business Quant data, Long-Term Debt Repayments came in at $113,000 in FY2020 (+151.1%) and $45,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,171.23 Bn 1,139.82 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 648.76 Bn 568.62 Bn 17.30 Bn 1.00 Mn
3 AbbVie 503.78 Bn 476.89 Bn 12.70 Bn 2.00 Bn
4 Merck 366.20 Bn 320.58 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 303.55 Bn 267.54 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 269.42 Bn 243.11 Bn 12.86 Bn 2.46 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn -
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn -
10 Caribou Biosciences 54.34 Mn -462.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 119,000.00
Dec 31, 2020 32,000.00
Sep 30, 2020 31,000.00
API Access

Caribou Biosciences Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=CRBU&period=max&api_key=YOUR_API_KEY